Search

Your search keyword '"Pichia drug effects"' showing total 366 results

Search Constraints

Start Over You searched for: Descriptor "Pichia drug effects" Remove constraint Descriptor: "Pichia drug effects"
366 results on '"Pichia drug effects"'

Search Results

1. Evaluation of antifungal and apoptotic effects of linalool, citral, and carvacrol separately and in combination with nystatin against clinical isolates of Pichia kudriavzevii.

2. Biology and genetic diversity of Candida krusei isolates from fermented vegetables and clinical samples in China.

3. Pichia kudriavzevii (Candida krusei): A systematic review to inform the World Health Organisation priority list of fungal pathogens.

4. Bioactive volatiles of brewer's yeasts: Antifungal action of compounds produced during wort fermentation on Aspergillus sp.

5. Nucleus-Independent Chemical Shift (NICS) as a Criterion for the Design of New Antifungal Benzofuranones.

6. Study of Titanium-Silver Monolayer and Multilayer Films for Protective Applications in Biomedical Devices.

7. Phytochemical characterization and inhibition of Candida sp. by the essential oil of Baccharis trimera (Less.) DC.

8. In-vitro pharmacokinetic/pharmacodynamic model data suggest a potential role of new formulations of posaconazole against Candida krusei but not Candida glabrata infections.

9. Compound isolation and biological activities of Piptadeniastrum africanum (hook.f.) Brennan roots.

10. Characterization of heavy metal toxicity in some plants and microorganisms-A preliminary approach for environmental bioremediation.

11. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.

12. Transcription factor Hap5 induces gsh2 expression to enhance 2-phenylethanol tolerance and production in an industrial yeast Candida glycerinogenes.

13. Prolonged Outbreak of Candida krusei Candidemia in Paediatric Ward of Tertiary Care Hospital.

14. Mechanisms of Acquired In Vivo and In Vitro Resistance to Voriconazole by Candida krusei following Exposure to Suboptimal Drug Concentration.

15. Epidemiological Trends of Fungemia in Greece with a Focus on Candidemia during the Recent Financial Crisis: a 10-Year Survey in a Tertiary Care Academic Hospital and Review of Literature.

16. The industrial yeast Pichia pastoris is converted from a heterotroph into an autotroph capable of growth on CO 2 .

17. Voriconazole efficacy against Candida glabrata and Candida krusei: preclinical data using a validated in vitro pharmacokinetic/pharmacodynamic model.

18. Expression of multidrug transporter P-glycoprotein in Pichia pastoris affects the host's methanol metabolism.

19. Effects of intrinsic microbial stress factors on viability and physiological condition of yeasts isolated from spontaneously fermented cereal doughs.

20. Improved cadmium resistance and removal capacity in Pichia kudriavzevii A16 by sucrose preincubation.

21. Mentha piperita L. essential oil inactivates spoilage yeasts in fruit juices through the perturbation of different physiological functions in yeast cells.

22. Production of a novel killer toxin from Saccharomyces eubayanus using agro-industrial waste and its application against wine spoilage yeasts.

23. Improved ethanol productivity and ethanol tolerance through genome shuffling of Saccharomyces cerevisiae and Pichia stipitis.

24. Potential use of Pichia pastoris strain SMD1168H expressing DNA topoisomerase I in the screening of potential anti‑breast cancer agents.

25. Downregulation by organic nitrogen of AOX1 promoter used for controlled expression of foreign genes in the yeast Pichia pastoris.

26. Acid stress induces cross-protection for cadmium tolerance of multi-stress-tolerant Pichia kudriavzevii by regulating cadmium transport and antioxidant defense system.

27. Ethanol represses the expression of methanol-inducible genes via acetyl-CoA synthesis in the yeast Komagataella phaffii.

28. Engineering of deglycosylated and plasmin resistant variants of recombinant streptokinase in Pichia pastoris.

29. On-chip analysis of carbon dots effect on yeast replicative lifespan.

30. The effect of non-thermal atmospheric plasma on the production and activity of recombinant phytase enzyme.

31. Quantitative proteomic analysis of xylose fermentation strain Pichia stipitis CBS 5776 to lignocellulosic inhibitors acetic acid, vanillin and 5-hydroxymethylfurfural.

32. Antagonistic effect of Saccharomyces cerevisiae KTP and Issatchenkia occidentalis ApC on hyphal development and adhesion of Candida albicans.

33. Investigation the cytotoxicity and photo-induced toxicity of carbon dot on yeast cell.

34. Enhanced overexpression, purification of a channelrhodopsin and a fluorescent flux assay for its functional characterization.

35. Antifungal susceptibility testing results of New Zealand yeast isolates, 2001-2015: Impact of recent CLSI breakpoints and epidemiological cut-off values for Candida and other yeast species.

36. Low-pH production of d-lactic acid using newly isolated acid tolerant yeast Pichia kudriavzevii NG7.

37. Identification and characterization of the Komagataella phaffii mating pheromone genes.

38. Presence of protein production enhancers results in significantly higher methanol-induced protein production in Pichia pastoris.

39. In vitro antimicrobial activity of monensin against common clinical isolates associated with canine otitis externa.

40. Quantitative lipidomic insights in the inhibitory response of Pichia stipitis to vanillin, 5-hydroxymethylfurfural, and acetic acid.

41. Candida infanticola and Candida spencermartinsiae yeasts: Possible emerging species in cancer patients.

42. Identification of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry.

43. Integrating metabolic modeling and population heterogeneity analysis into optimizing recombinant protein production by Komagataella (Pichia) pastoris.

44. Enzyme activity and expression pattern of intra- and extracellular chitinase and β-1,3-glucanase of Wickerhamomyces anomalus EG2 using glycol chitin and glucan-containing high polymer complex.

45. Outbreak of Pichia kudriavzevii fungaemia in a neonatal intensive care unit.

46. The identification of Meyerozyma guilliermondii from blood cultures and surveillance samples in a university hospital in Northeast Turkey: A ten-year survey.

47. The adaptive landscape of wildtype and glycosylation-deficient populations of the industrial yeast Pichia pastoris.

48. Biomarkers allow detection of nutrient limitations and respective supplementation for elimination in Pichia pastoris fed-batch cultures.

49. Biosynthesis of ZnO Nanoparticles by a New Pichia kudriavzevii Yeast Strain and Evaluation of Their Antimicrobial and Antioxidant Activities.

50. The effect of hypoxia on the lipidome of recombinant Pichia pastoris.

Catalog

Books, media, physical & digital resources